Henoch-Schönlein purpura primary prevention

Revision as of 20:42, 5 April 2018 by Ajay Gade (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Henoch-Schönlein purpura Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Henoch-Schönlein purpura from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Henoch-Schönlein purpura primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Henoch-Schönlein purpura primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Henoch-Schönlein purpura primary prevention

CDC on Henoch-Schönlein purpura primary prevention

Henoch-Schönlein purpura primary prevention in the news

Blogs on Henoch-Schönlein purpura primary prevention

Directions to Hospitals Treating Henoch-Schönlein purpura

Risk calculators and risk factors for Henoch-Schönlein purpura primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

There are no established measures for the primary prevention of Henoch-Schönlein purpura (HSP).

Primary Prevention

  • There are no established measures for the primary prevention of HSP.

References


Template:WH Template:WS